Evidence has been reported showing that activated CD8+ tumor infiltrating lymphocytes (TILs) express CD137 [9] and therefore are amenable to receive artificial costimulation by agonist anti-CD137 mAbs within the malignant tissue microenvironment. Here, CD8A is linked to neoplasm.